What does Dr. Liesbet VERNIJNS do?

Dr. Liesbet VERNIJNS is a specialist medical practice in Genk. Private Limited, started on 27 January 2010, 1 establishment.

What is the address of Dr. Liesbet VERNIJNS?

The registered office of Dr. Liesbet VERNIJNS is located at Poreistraat 40, 3600 Genk.

Is Dr. Liesbet VERNIJNS still active?

Yes. According to the CBE (29 September 2026) Dr. Liesbet VERNIJNS is active, legal situation “Normale toestand”, started on 27 January 2010.

Is Dr. Liesbet VERNIJNS registered on Peppol?

Yes, Dr. Liesbet VERNIJNS is registered on the Peppol network with ID 0208:0822787652.

What is the enterprise number of Dr. Liesbet VERNIJNS?

The enterprise number of Dr. Liesbet VERNIJNS is BE0822787652.

When was Dr. Liesbet VERNIJNS founded?

Dr. Liesbet VERNIJNS was founded on 27 January 2010.

Who are the directors of Dr. Liesbet VERNIJNS?

According to the 2024 annual accounts, the directors of Dr. Liesbet VERNIJNS are: Liesbet Vernijns.

Is Dr. Liesbet VERNIJNS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 January 2010; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did Dr. Liesbet VERNIJNS make in 2024?

Dr. Liesbet VERNIJNS recorded a loss after taxes of € 20,297 in financial year 2024.

What is the revenue of Dr. Liesbet VERNIJNS?

As a small company, Dr. Liesbet VERNIJNS is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 149,799.

Dr. Liesbet VERNIJNS (Private Limited) - Genk

Dossier Dr. Liesbet VERNIJNS, printed on 29 September 2026 from databakkes.be/en/0822787652/dr-liesbet-vernijns. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

Dr. Liesbet VERNIJNS from Genk, company number BE0822787652, closed financial year 2024 with a result of € -20,297 after tax. For that financial year Dr. Liesbet VERNIJNS recorded a gross margin of € 149,799 and equity of € 548,246. Compared with financial year 2023, the result moved from € 80,646 to € -20,297. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2025.

What it is worth Healthy

€ 548,246

▼ 4% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -20,297

▼ still € 80,646 profit in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 132,342

▼ 77% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 535,846.

People and assets in 2024

Vehicles and equipment

€ 2,160

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 19 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 684,136

▲ € 681,181 vs 2023

€ 35,968 is repaid this year. At this pace the long-term loan is gone in ≈ 19 years.

Owed to suppliers

€ 2,997

▲ 166% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 9,742

▼ 57% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 125,692 Gross margin 2021: € 125,692 First fiscal year in the series	€ 126,021 Gross margin 2022: € 126,021 Unchanged (€ 125,692) Favourable step	€ 123,206 Gross margin 2023: € 123,206 ▼ 2% vs 2022 (€ 126,021) Unfavourable step	€ 149,799 Gross margin 2024: € 149,799 ▲ 22% vs 2023 (€ 123,206) Favourable step	▲ 22%
Profit after taxes	€ 78,320 Profit after taxes 2021: € 78,320 First fiscal year in the series	€ 81,916 Profit after taxes 2022: € 81,916 ▲ 5% vs 2021 (€ 78,320) Favourable step	€ 80,646 Profit after taxes 2023: € 80,646 ▼ 2% vs 2022 (€ 81,916) Unfavourable step	€ -20,297 Profit after taxes 2024: € -20,297 ▼ € 100,943 vs 2023 (€ 80,646) Unfavourable step	▼ € 100,943
Equity	€ 469,855 Equity 2021: € 469,855 First fiscal year in the series	€ 551,771 Equity 2022: € 551,771 ▲ 17% vs 2021 (€ 469,855) Favourable step	€ 568,542 Equity 2023: € 568,542 ▲ 3% vs 2022 (€ 551,771) Favourable step	€ 548,246 Equity 2024: € 548,246 ▼ 4% vs 2023 (€ 568,542) Unfavourable step	▼ 4%
Total debts	€ 71,369 Total debts 2021: € 71,369 First fiscal year in the series	€ 66,659 Total debts 2022: € 66,659 ▼ 7% vs 2021 (€ 71,369) Favourable step	€ 27,571 Total debts 2023: € 27,571 ▼ 59% vs 2022 (€ 66,659) Favourable step	€ 697,446 Total debts 2024: € 697,446 ▲ € 669,874 vs 2023 (€ 27,571) Unfavourable step	▲ € 669,874
Cash	€ 494,758 Cash 2021: € 494,758 First fiscal year in the series	€ 595,022 Cash 2022: € 595,022 ▲ 20% vs 2021 (€ 494,758) Favourable step	€ 577,588 Cash 2023: € 577,588 ▼ 3% vs 2022 (€ 595,022) Unfavourable step	€ 132,342 Cash 2024: € 132,342 ▼ 77% vs 2023 (€ 577,588) Unfavourable step	▼ 77%
Land & buildings	-	-	-	€ 812,496 Land & buildings 2024: € 812,496 First fiscal year in the series
Retained profit	€ 457,455 Retained profit 2021: € 457,455 First fiscal year in the series	€ 539,371 Retained profit 2022: € 539,371 ▲ 18% vs 2021 (€ 457,455) Favourable step	€ 556,142 Retained profit 2023: € 556,142 ▲ 3% vs 2022 (€ 539,371) Favourable step	€ 535,846 Retained profit 2024: € 535,846 ▼ 4% vs 2023 (€ 556,142) Unfavourable step	▼ 4%
Dividend	€ 165,018 Dividend 2021: € 165,018 First fiscal year in the series	€ 0 Dividend 2022: € 0 ▼ 100% vs 2021 (€ 165,018) Unchanged	€ 63,875 Dividend 2023: € 63,875 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 63,875) Unchanged	▼ 100%
Bank debt	€ 26,418 Bank debt 2021: € 26,418 First fiscal year in the series	€ 14,725 Bank debt 2022: € 14,725 ▼ 44% vs 2021 (€ 26,418) Favourable step	€ 2,955 Bank debt 2023: € 2,955 ▼ 80% vs 2022 (€ 14,725) Favourable step	€ 684,136 Bank debt 2024: € 684,136 ▲ € 681,181 vs 2023 (€ 2,955) Unfavourable step	▲ € 681,181
Balance sheet total	€ 541,225 Balance sheet total 2021: € 541,225 First fiscal year in the series	€ 618,429 Balance sheet total 2022: € 618,429 ▲ 14% vs 2021 (€ 541,225) Unchanged	€ 596,114 Balance sheet total 2023: € 596,114 ▼ 4% vs 2022 (€ 618,429) Unchanged	€ 1,245,691 Balance sheet total 2024: € 1,245,691 ▲ 109% vs 2023 (€ 596,114) Unchanged	▲ 109%

Key figures of Dr. Liesbet VERNIJNS, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Dr. Liesbet VERNIJNS?

What happened at Dr. Liesbet VERNIJNS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2025 New annual accounts for financial year 2024: loss of € 20,297 (▼ € 100,943 vs 2023). Source: NBB ↗
Feb 1, 2010 New establishment in Genk. KBO
Jan 27, 2010 Start of the company according to the CBE. KBO

In short

From € 78,320 profit in 2021 to € 20,297 loss in 2024.

Paid € 97,212 in corporate taxes since 2021.

Best year ever: 2022, with € 81,916 profit.

Paid out € 228,893 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Liesbet VERNIJNS? We notify you, reason included.

Follow Dr. Liesbet VERNIJNS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Liesbet Vernijns

Dr. Liesbet VERNIJNS

Kalivan 25%

Behind Dr. Liesbet VERNIJNS is Liesbet Vernijns. It owns 25% of Kalivan itself.

See the full network in the app

Directors

According to the 2024 annual accounts

Liesbet Vernijns

Director

Also active at: KALIVAN

Establishments

Establishment units

Physical locations of this company

Registered office

Poreistraat 40

3600 Genk

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0822.787.652
VAT number: BE 0822.787.652
Registered office: Poreistraat 40, 3600 Genk
Names & denominations: Dr. Liesbet VERNIJNS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 January 2010
Peppol: Active · Active since 15 Feb 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗